Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F97G8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,618
Award facts
- Contract value 100% obligated
- $21,618.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,618.12 firm fixed-price delivery order to AmerSourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pen (2 mL) on January 20, 2026, with ultimate completion scheduled for January 21, 2026. This non-set-aside contract is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. AmerSourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerSourceBergen), a major pharmaceutical distributor serving federal healthcare systems. The delivery order falls under a larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which provides comprehensive pharmaceutical support for military healthcare programs worldwide.
DUPIXENT (dupilumab) is a biologic immunosuppressant medication used to treat conditions including atopic dermatitis, asthma, and eosinophilic esophagitis. This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal military medical treatment facilities. The contract demonstrates the contractor's continued capability to fulfill specialized pharmaceutical supply requirements through the DLA's competitive procurement process, with pricing structured on a firm fixed-price basis typical of pharmaceutical delivery orders.
Quick answers
Who was awarded contract SPE2DR26F97G8?
SPE2DR26F97G8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F97G8 worth?
The government has obligated $21,618 on SPE2DR26F97G8.
Is contract SPE2DR26F97G8 an order under another contract?
Yes. SPE2DR26F97G8 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F97G8 competed?
The extent of competition for SPE2DR26F97G8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award